ketanserin has been researched along with physostigmine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Björklund, M; Jäkälä, P; Koivisto, E; Riekkinen, P | 1 |
Jäkälä, P; Riekkinen, P | 1 |
4 other study(ies) available for ketanserin and physostigmine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The effects of cholinergic drugs on rat neocortical high-voltage spindles in ketanserin-treated rats.
Topics: Animals; Cerebral Cortex; Electroencephalography; Ketanserin; Male; Oxotremorine; Physostigmine; Pilocarpine; Rats; Rats, Wistar | 1996 |
Combined cholinergic and 5-HT2 receptor activation suppresses thalamocortical oscillations in aged rats.
Topics: Aging; Amphetamines; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Drug Synergism; Electroencephalography; Ketanserin; Male; Physostigmine; Rats; Rats, Wistar; Reaction Time; Receptors, Cholinergic; Receptors, Serotonin; Tacrine; Thalamus | 1997 |